Learning Objectives: -Assess the clinical implications of patient outcomes in the relapsed/refractory setting to support the rationale for new and emerging treatments in NHL. -Differentiate the mechanisms of action, including therapeutic targets and molecular formats, indications, dosing, and administration requirements of available T-cell mediated treatments in order to tailor personalized treatment strategies.
- Provider:Medical Learning Institute, Inc.
- Activity Link: https://learn.mlieducation.org/courses
- Start Date: 2024-05-15 05:00:00
- End Date: 2024-05-15 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - MOC Credit Details: ABIM - 0.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Bristol Myers Squibb - Amount: 66000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Hematology, Internal Medicine, Medical Oncology
Subscribe
Login
0 Comments
Oldest